BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12904807)

  • 1. Apomorphine-induced brain modulation during sexual stimulation: a new look at central phenomena related to erectile dysfunction.
    Montorsi F; Perani D; Anchisi D; Salonia A; Scifo P; Rigiroli P; Zanoni M; Heaton JP; Rigatti P; Fazio F
    Int J Impot Res; 2003 Jun; 15(3):203-9. PubMed ID: 12904807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain activation patterns during video sexual stimulation following the administration of apomorphine: results of a placebo-controlled study.
    Montorsi F; Perani D; Anchisi D; Salonia A; Scifo P; Rigiroli P; Deho F; De Vito ML; Heaton J; Rigatti P; Fazio F
    Eur Urol; 2003 Apr; 43(4):405-11. PubMed ID: 12667722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apomorphine and erectile dysfunction].
    Tan DQ; Yao Y; Zhang J
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging oral drugs for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Suardi N; Rigatti P; Montorsi F
    Expert Opin Emerg Drugs; 2004 May; 9(1):179-89. PubMed ID: 15155143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
    Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apomorphine-induced penile erections in Parkinson's disease.
    O'Sullivan JD; Hughes AJ
    Mov Disord; 1998 May; 13(3):536-9. PubMed ID: 9613749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional nature of apomorphine SL (Ixense) therapy.
    Costa P
    Int J Impot Res; 2003 Apr; 15 Suppl 2():S13-5. PubMed ID: 12825099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary on apomorphine versus sildenafil for erectile dysfunction.
    Carson CC
    J Urol; 2008 May; 179(5 Suppl):S95-6. PubMed ID: 18405768
    [No Abstract]   [Full Text] [Related]  

  • 9. Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine.
    Hsieh GC; Hollingsworth PR; Martino B; Chang R; Terranova MA; O'Neill AB; Lynch JJ; Moreland RB; Donnelly-Roberts DL; Kolasa T; Mikusa JP; McVey JM; Marsh KC; Sullivan JP; Brioni JD
    J Pharmacol Exp Ther; 2004 Jan; 308(1):330-8. PubMed ID: 14569075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system agents in the treatment of erectile dysfunction.
    Kendirci M; Walls MM; Hellstrom WJ
    Urol Clin North Am; 2005 Nov; 32(4):487-501, vii. PubMed ID: 16291040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
    Afif-Abdo J; Teloken C; DamiĆ£o R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
    BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug.
    Giuliano F; Allard J
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S53-6. PubMed ID: 11850736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erectile dysfunction].
    Lyngdorf P
    Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative trial of treatment satisfaction, efficacy and tolerability of sildenafil versus apomorphine in erectile dysfunction--an open, randomized cross-over study with flexible dosing.
    Porst H; Behre HM; Jungwirth A; Burkart M
    Eur J Med Res; 2007 Feb; 12(2):61-7. PubMed ID: 17369119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: Involvement of central oxytocin.
    Succu S; Sanna F; Melis T; Boi A; Argiolas A; Melis MR
    Neuropharmacology; 2007 Mar; 52(3):1034-43. PubMed ID: 17164075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
    Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
    Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bromocriptine in patients with apomorphine-responsive erectile impotence: an open study.
    Lal S; Kiely ME; Thavundayil JX; Stewart JD; Assalian P; Ackman CF
    J Psychiatry Neurosci; 1991 Dec; 16(5):262-6. PubMed ID: 1797100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine: an update of clinical trial results.
    Heaton JP
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S67-73. PubMed ID: 11035390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural control of erection.
    Giuliano F; Rampin O
    Physiol Behav; 2004 Nov; 83(2):189-201. PubMed ID: 15488539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction.
    Heaton JP
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.